These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 33422456)

  • 21. Frequent HPV-independent p16/INK4A overexpression in head and neck cancer.
    Lechner M; Chakravarthy AR; Walter V; Masterson L; Feber A; Jay A; Weinberger PM; McIndoe RA; Forde CT; Chester K; Kalavrezos N; O'Flynn P; Forster M; Jones TM; Vaz FM; Hayes DN; Fenton TR
    Oral Oncol; 2018 Aug; 83():32-37. PubMed ID: 30098776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metastatic HPV-related head and neck squamous cell carcinoma to the lung and mediastinal lymph nodes in aspirated cytology material: A diagnostic pitfall.
    Banet N; Rooper LM; Maleki Z
    Diagn Cytopathol; 2016 Mar; 44(3):206-14. PubMed ID: 26764038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p16, p53 and EGFR expression in head and neck squamous cell carcinoma and their correlation with clinicopathological parameters.
    Gupta S; Pandey P; Verma S; Verma A
    J Cancer Res Ther; 2024 Apr; 20(3):881-887. PubMed ID: 39023595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of p16 and HPV testing in oropharyngeal squamous cell carcinoma: An institutional review.
    Abdelhakam DA; Huenerberg KA; Nassar A
    Diagn Cytopathol; 2021 Jan; 49(1):54-59. PubMed ID: 32845095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
    Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
    Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Molecular Assays for HPV Testing in Oropharyngeal Squamous Cell Carcinomas: A Population-Based Study in Northern Ireland.
    Craig SG; Anderson LA; Moran M; Graham L; Currie K; Rooney K; Robinson M; Bingham V; Cuschieri KS; McQuaid S; Schache AG; Jones TM; McCance D; Salto-Tellez M; McDade SS; James JA
    Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):31-38. PubMed ID: 31666283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p16 overexpression and Rb loss correlate with high-risk HPV infection in oropharyngeal squamous cell carcinoma.
    Jiromaru R; Yamamoto H; Yasumatsu R; Hongo T; Nozaki Y; Nakano T; Hashimoto K; Nakagawa T; Oda Y
    Histopathology; 2021 Sep; 79(3):358-369. PubMed ID: 33450095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fine-needle aspiration of cervical lymph nodes yields adequate materials for accurate HPV testing in metastatic head and neck squamous cell carcinomas.
    Hou Y; Chaudhary S; Shen R; Li Z
    Diagn Cytopathol; 2016 Oct; 44(10):792-8. PubMed ID: 27465660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous p53 and p16 Immunostaining for Molecular Subclassification of Head and Neck Squamous Cell Carcinomas.
    Pakkanen P; Silvoniemi A; Aro K; Bäck L; Irjala H; Aaltonen LM; Hagström J; Haglund C; Laine J; Minn H; Huvila J
    Head Neck Pathol; 2024 Aug; 18(1):73. PubMed ID: 39110300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Diagnostics in Human Papillomavirus-Related Head and Neck Squamous Cell Carcinoma.
    Wai KC; Strohl MP; van Zante A; Ha PK
    Cells; 2020 Feb; 9(2):. PubMed ID: 32098320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of p40 and p63 immunohistochemistry and human papillomavirus testing as ancillary tools for the recognition of head and neck sarcomatoid carcinoma and its distinction from benign and malignant mesenchymal processes.
    Bishop JA; Montgomery EA; Westra WH
    Am J Surg Pathol; 2014 Feb; 38(2):257-64. PubMed ID: 24418859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Partial p16 staining in oropharyngeal squamous cell carcinoma: extent and pattern correlate with human papillomavirus RNA status.
    Lewis JS; Chernock RD; Ma XJ; Flanagan JJ; Luo Y; Gao G; Wang X; El-Mofty SK
    Mod Pathol; 2012 Sep; 25(9):1212-20. PubMed ID: 22596101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Equivocal p16 immunostaining in squamous cell carcinoma of the head and neck: staining patterns are suggestive of HPV status.
    Chen ZW; Weinreb I; Kamel-Reid S; Perez-Ordoñez B
    Head Neck Pathol; 2012 Dec; 6(4):422-9. PubMed ID: 22801997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. β-Catenin Expression in Oropharyngeal Squamous Cell Carcinomas: Comparison and Correlation with p16 and Human Papillomavirus in situ Hybridization.
    Nwanze J; Cohen C; Schmitt AC; Siddiqui MT
    Acta Cytol; 2015; 59(6):479-84. PubMed ID: 26849661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comprehensive evaluation of human papillomavirus positive status and p16INK4a overexpression as a prognostic biomarker in head and neck squamous cell carcinoma.
    Deng Z; Hasegawa M; Aoki K; Matayoshi S; Kiyuna A; Yamashita Y; Uehara T; Agena S; Maeda H; Xie M; Suzuki M
    Int J Oncol; 2014 Jul; 45(1):67-76. PubMed ID: 24820457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of high-risk HPV status of head and neck squamous cell carcinoma using the Roche cobas HPV test on cytologic specimens and acellular supernatant fluid.
    Wright MF; Weiss VL; Lewis JS; Schmitz JE; Ely KA
    Cancer Cytopathol; 2020 Jul; 128(7):482-490. PubMed ID: 32129949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined P16 and human papillomavirus testing predicts head and neck cancer survival.
    Salazar CR; Anayannis N; Smith RV; Wang Y; Haigentz M; Garg M; Schiff BA; Kawachi N; Elman J; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF
    Int J Cancer; 2014 Nov; 135(10):2404-12. PubMed ID: 24706381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p16 expression in cutaneous squamous cell carcinoma of the head and neck is not associated with integration of high risk HPV DNA or prognosis.
    Satgunaseelan L; Chia N; Suh H; Virk S; Ashford B; Lum T; Ranson M; Clark J; Gupta R
    Pathology; 2017 Aug; 49(5):494-498. PubMed ID: 28663082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance of a Branch Chain RNA In Situ Hybridization Assay for the Detection of High-risk Human Papillomavirus in Head and Neck Squamous Cell Carcinoma.
    Kerr DA; Arora KS; Mahadevan KK; Hornick JL; Krane JF; Rivera MN; Ting DT; Deshpande V; Faquin WC
    Am J Surg Pathol; 2015 Dec; 39(12):1643-52. PubMed ID: 26426378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HPV-related squamous cell carcinoma of the head and neck: An update on testing in routine pathology practice.
    Bishop JA; Lewis JS; Rocco JW; Faquin WC
    Semin Diagn Pathol; 2015 Sep; 32(5):344-51. PubMed ID: 25724476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.